SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-24-000014
Filing Date
2024-02-01
Accepted
2024-02-01 06:18:27
Documents
1
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k-2_020124.htm 6-K 28641
  Complete submission text file 0001395064-24-000014.txt   29647
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 24584952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)